e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Adverse events of antituberculosis treatment and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment and outcome of CRF patients with tuberculosis
P. Baghaei, P. Tabarsi, M. Marjani, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
Source:
Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Session:
Adverse events of antituberculosis treatment and comorbidities
Session type:
Thematic Poster Session
Number:
3149
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Baghaei, P. Tabarsi, M. Marjani, M. R. Masjedi (Tehran, Islamic Republic Of Iran). Treatment and outcome of CRF patients with tuberculosis. Eur Respir J 2010; 36: Suppl. 54, 3149
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 651s
Year: 2004
Treatment outcome and prognostic factor in patients with
mycobacterium avium complex
pulmonary disease
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009
Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program
Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban
Year: 2008
Clinical management improves the treatment outcome of MDR-TB patients
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017
Treating tuberculosis in patients with comorbidities
Source: International Congress 2018 – PG13 Challenges in the treatment of tuberculosis
Year: 2018
Treatment outcome and risk factors of death in elderly patients diagnosed as new cases of tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Clinical characteristics and treatment response of pulmonary cryptococcosis in HIV negative patients
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Diagnosis and treatment delay in patients with pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003
Clinical profile and outcome of complicated pulmonary tuberculosis in children
Source: Eur Respir J 2002; 20: Suppl. 38, 362s
Year: 2002
Efficiency of treatment regimens for chronic tuberculosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 519s
Year: 2003
Incidence and clinical characteristics of tuberculosis in diabetic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 506s
Year: 2006
Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
Source: Eur Respir J 2015; 45: 1498-1501
Year: 2015
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1594-1595
Year: 2016
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1592-1594
Year: 2016
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2015; 46: 1397-1406
Year: 2015
Treatment results for MDR TB patients after surgery
Source: Eur Respir J 2005; 26: Suppl. 49, 654s
Year: 2005
Treatment approach to tuberculosis in patients with antituberculotic-induced liver disorders
Source: Eur Respir J 2005; 26: Suppl. 49, 650s
Year: 2005
Treatment effectiveness among newly diagnosed patients with expanded pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept